Evidence map›Paper›PMID 38602274›Full record

ArticleJournal of global health2024

Evaluation of pharmacist-led medication reconciliation at county hospitals in China: A multicentre, open-label, assessor-blinded, nonrandomised controlled study.

Mengyuan Fu, Yuezhen Zhu, Guilin Wei, Aichen Yu, Fanghui Chen, Yuanpeng Tang, Zining Wang, Guoying Wang, Qingpeng Liu, Chunyuan Zhong and 7 more

Open access · goldAbstract readControlled Clinical TrialMulticenter Study
In one paragraph

Article in Journal of global health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 6 institutions in 1 country.

Mengyuan Fu *Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutical Sciences, Peking University, Beijing, China.
Yuezhen Zhu *Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutical Sciences, Peking University, Beijing, China.
Guilin Wei *Department of Pharmacy, The First Affiliated Hospital of Gannan Medical University, Jiangxi, China.
Aichen YuDepartment of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutical Sciences, Peking University, Beijing, China.
Fanghui ChenDepartment of Pharmacy, The First Affiliated Hospital of Gannan Medical University, Jiangxi, China.
Yuanpeng TangDepartment of Pharmacy, The First Affiliated Hospital of Gannan Medical University, Jiangxi, China.
Zining WangDepartment of Pharmacy, Peking University First Hospital, Beijing, China.
Guoying WangDepartment of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutical Sciences, Peking University, Beijing, China.
Qingpeng LiuDepartment of Pharmacy, The Peoples' Hospital of Yudu County, Jiangxi, China.
Chunyuan ZhongDepartment of Pharmacy, The Peoples' Hospital of Xingguo County, Jiangxi, China.
Jinghong LiuDepartment of Pharmacy, The First People's Hospital of Longnan City, Jiangxi, China.
Jie ZhongDepartment of Pharmacy, The People's Hospital of Ruijin City, Jiangxi, China.
Ping TianDepartment of Pharmacy, The People's Hospital of Shangyou County, Jiangxi, China.
Debao LiDepartment of Pharmacy, The People's Hospital of Xinfeng County, Jiangxi, China.
Xixi LiInternational Research Center for Medicinal Administration, Peking University, Beijing, China.
Luwen ShiDepartment of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutical Sciences, Peking University, Beijing, China.
Xiaodong GuanDepartment of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutical Sciences, Peking University, Beijing, China.
Peking University · CNFirst Affiliated Hospital of Gannan Medical University · CNCapital Medical University · CNPeking University First Hospital · CNRuijin Hospital · CNYuxian People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Due to a lack of related research, we aimed to determine the effectiveness of a pharmacist-led medication reconciliation intervention in China. Methods: We conducted a multicentre, prospective, open-label, assessor-blinded, cluster, nonrandomised controlled study at six county-level hospitals, with hospital wards serving as the clusters. We included patients discharged from the sampled hospitals who were aged ≥60 years; had ≥1 studied diagnoses; and were prescribed with ≥3 medications at discharge. Patients in the intervention group received a pharmacist-led medication reconciliation intervention and those in the control group received standard care. We assessed the incidence of medication discrepancies at discharge, patients' medication adherence, and health care utilisation within 30 days after discharge. Results: There were 429 patients in the intervention group (mean age = 72.5 years, standard deviation (SD) = 7.0) and 526 patients in the control group (mean age = 73.6 years, SD = 7.1). Of the 1632 medication discrepancies identified at discharge, fewer occurred in the intervention group (1.9 per patient on average) than the control group (2.6 per patient on average).The intervention significantly reduced the incidence of medication discrepancy by 9.6% (95% confidence interval (CI) = -15.6, -3.6, P = 0.002) and improved patients' medication adherence, with an absolute decrease in the mean adherence score of 2.5 (95% CI = -2.8, -2.2, P < 0.001). There was no significant difference in readmission rates between the intervention and control groups. Conclusions: Pharmacist-led medication reconciliation at discharge from Chinese county-level hospitals reduced medication discrepancies and improved patients' adherence among patients aged 60 years or above, though no impact on readmission after discharge was observed. Registration: ChiCTR2100045668.

Indexed as

Medication ReconciliationPharmacistsAgedHospitals, CountyHumansMedication AdherenceProspective Studies

Identifiers

PMID38602274
PMCPMC11007753
OpenAlexW4394717847

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.